CTech's Monday Roundup of Israeli Tech News
Most Israelis are unhappy with the current government’s economic policy, survey shows; FIMI in talks to buy a controlling stake in kibbutz-owned water treatment company
Election | Most Israelis are unhappy with the current government’s economic policy, survey shows. A new survey released just two weeks ahead of the country’s general election shows many Israelis oppose raising taxes because they do not believe the government would use additional funds to improve social services. Read more
Israeli Prime Minister Benjamin Netanyahu. Photo: AP Allergan says Teva bears sole liability for Actavis' actions. Actavis, which Teva bought from Allergan in 2016 for $40.5 billion, was one of the top U.S. sellers of opioids in 2006-2012. Read more
Back to school: 10 ways to improve Israel’s education system. How to help students prepare for the future job market? Ten experts offer unique ideas on how to make education in Israel more innovative and creative. Read more
New Tel Aviv accelerator offers a program dedicated to female founders. Officially launched last week, WOSNA currently hosts a first cohort made up of 11 startups with at least one female founder. Read more
Consumer electronics importer Ralco wants in on the green gold. Ralco announced a $5.66 million investment in Israeli medical cannabis company Together Pharma on Monday in return for an 11.5% stake. Read more
Indian Oil, Israeli company Phinergy to collaborate on new electric vehicle battery factory. The two companies first signed a collaboration agreement last year, India media reported. Read more
VeriFone Israel acquires software startup Action Item for $4 million. Action Item Software will serve as a Tel Aviv research and development outpost for VeriFone, and its 60-person team will be integrated into the company. Read more
Tel Aviv Stock Exchange suspends trading in Vonetize securities. On Saturday, Vonetize announced that its attempts to raise funds have failed, that it cannot repay its bonds, and that the bonds’ trustee has informed the company it must begin insolvency proceedings. Read more
Tokyo-listed Terumo signs distribution deal with cancer freezing company IceCure. IceCure develops an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor, freezing its tissue in a process called cryoablation. Read more
